Dr. Crow leads Catalyst Health Group, reimagining primary care around value rather than volume for better outcomes, lower costs, and a more sustainable experience for both patients and providers. Under his guidance over the past decade, Catalyst has generated $500 million in shared savings from value-based contracts, and today manages more than 70,000 Medicare members in full-risk arrangements, achieving an 83% monthly engagement rate with high-risk patients and an approximately 8% reduction in hospitalizations last year alone. He has championed technology-enabled workflows and integrated clinical partnerships that give care teams real-time insights into patient needs, enabling earlier intervention and more personalized care while allowing physicians to practice at the top of their license with reduced administrative burden. Beyond Catalyst, Dr. Crow founded Stellus Rx, a national tech-enabled pharmacy support service extending clinical care for over one million patients; Lightpath Health, a nonprofit offering team-based primary care to the uninsured; and Village Health Partners, one of the first level 3 National Committee for Quality Assurance patient-centric medical homes. He serves on the boards of Gentiva, Leading Reach and Stella Mattina, and is an advisory board member at the University of Texas McCombs School of Business. Dr. Crow received the American Academy of Family Physicians’ “Robert Graham Award as Physician Executive of the Year” in 2024, the “TAFP Presidential Award of Merit” from the Texas Association of Family Physicians in 2024, and has been recognized by D CEO Magazine as “Healthcare Innovator of the Year” and among its top 500 CEOs from 2019 through 2024.
